Associated Papers
Differential Impact of Spike Protein Mutations on SARS-CoV-2 Infectivity and Immune Evasion: Insights from Delta and Kappa Variants.
Kim TH et al.
Journal of Microbiology and Biotechnology, 2024
Insights into the Replication Kinetics Profiles of Malaysian SARS-CoV-2 Variant Alpha, Beta, Delta, and Omicron in Vero E6 Cell Line.
Mohd Zawawi Z et al.
International Journal of Molecular Sciences, 2024
SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease.
Ren W et al.
The Journal of Clinical Investigation, 2024
Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2.
Maeda Y et al.
International Journal of Molecular Sciences, 2024
Infection kinetics, syncytia formation, and inflammatory biomarkers as predictive indicators for the pathogenicity of SARS-CoV-2 Variants of Concern in Calu-3 cells.
Purwono PB et al.
Plos One, 2024
Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following vaccination with Ad5-nCoV (CanSino) in the Mexican population.
Hernández-Bello J et al.
Plos One, 2024
In vitro fitness of SARS-CoV-2 variants as assessed by competition experiments followed by ddRT-PCR and whole genome sequencing.
Hénaut M et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology, 2023
Omicron subvariant BA.5 efficiently infects lung cells.
Hoffmann M et al.
Nature Communications, 2023
Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1.
Sidarovich A et al.
Viruses, 2022
Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.
Lubinski B et al.
Microbiology Spectrum, 2022
Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice.
González-Domínguez I et al.
Microbiology Spectrum, 2022
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
Ren W et al.
Mbio, 2022
Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda.
Lubinski B et al.
Biorxiv : the Preprint Server for Biology, 2022
Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice.
González-Domínguez I et al.
Biorxiv : the Preprint Server for Biology, 2022
Clinical Evaluation of a Fully-Automated High-Throughput Multiplex Screening-Assay to Detect and Differentiate the SARS-CoV-2 B.1.1.529 (Omicron) and B.1.617.2 (Delta) Lineage Variants.
Nörz D et al.
Viruses, 2022
Circulation of SARS-CoV-2 Variants among Children from November 2020 to January 2022 in Trieste (Italy).
Dolci M et al.
Microorganisms, 2022
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera.
Yahalom-Ronen Y et al.
Vaccines, 2022
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants.
McCallum M et al.
Science (new York, N.y.), 2021
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.
Ferreira IATM et al.
The Journal of Infectious Diseases, 2021
The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452R.
Mor O et al.
Vaccines, 2021
Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants.
McCallum M et al.
Biorxiv : the Preprint Server for Biology, 2021
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York.
West AP et al.
Nature Communications, 2021
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination.
Hoffmann M et al.
Cell Reports, 2021